Their study provides a comprehensive transcriptomic and spatial characterisation of this B cell subset in non-small cell lung cancer (NSCLC), revealing a population of CD27+CD38hiCD24- plasmablast-like cells enriched for the immune checkpoint molecule VISTA. This evidence concerns the gene CD27 and non-small cell lung carcinoma.